These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27057951)

  • 1. Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis.
    Perrucci GL; Straino S; Corlianò M; Scopece A; Napolitano M; Berk BC; Lombardi F; Pompilio G; Capogrossi MC; Nigro P
    Int J Cardiol; 2016 Jun; 212():324-35. PubMed ID: 27057951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia.
    Yip HK; Sun CK; Tsai TH; Sheu JJ; Kao YH; Lin YC; Shiue YL; Chen YL; Chai HT; Chua S; Ko SF; Leu S
    Int J Cardiol; 2013 Sep; 168(1):226-36. PubMed ID: 23063135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B16-F10 melanoma cells and cell culture supernatant enhance angiogenesis in mouse ischemic limb.
    Zhou T; Hu ZH; Zhou B; Fu WG; Wang YQ
    Sheng Li Xue Bao; 2009 Apr; 61(2):139-45. PubMed ID: 19377825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
    Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
    PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice.
    Tan Y; Li Y; Xiao J; Shao H; Ding C; Arteel GE; Webster KA; Yan J; Yu H; Cai L; Li X
    Cardiovasc Res; 2009 Jun; 82(3):513-21. PubMed ID: 19196827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia.
    Leu S; Lu HI; Sun CK; Sheu JJ; Chen YL; Tsai TH; Yeh KH; Chai HT; Chua S; Tsai CY; Chang HW; Lee FY; Yip HK
    Int J Cardiol; 2014 Jan; 170(3):394-405. PubMed ID: 24290069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.
    Cheng M; Huang K; Zhou J; Yan D; Tang YL; Zhao TC; Miller RJ; Kishore R; Losordo DW; Qin G
    J Mol Cell Cardiol; 2015 Apr; 81():49-53. PubMed ID: 25655934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.
    Cheng M; Zhou J; Wu M; Boriboun C; Thorne T; Liu T; Xiang Z; Zeng Q; Tanaka T; Tang YL; Kishore R; Tomasson MH; Miller RJ; Losordo DW; Qin G
    Circ Res; 2010 Oct; 107(9):1083-93. PubMed ID: 20847314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.
    Ho TK; Tsui J; Xu S; Leoni P; Abraham DJ; Baker DM
    J Vasc Surg; 2010 Mar; 51(3):689-99. PubMed ID: 20206813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels.
    Shao H; Tan Y; Eton D; Yang Z; Uberti MG; Li S; Schulick A; Yu H
    Stem Cells; 2008 May; 26(5):1376-84. PubMed ID: 18308946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression.
    Cencioni C; Melchionna R; Straino S; Romani M; Cappuzzello C; Annese V; Wu JC; Pompilio G; Santoni A; Gaetano C; Napolitano M; Capogrossi MC
    Eur Heart J; 2013 Jul; 34(26):2007-16. PubMed ID: 21784762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.
    Shiba Y; Takahashi M; Hata T; Murayama H; Morimoto H; Ise H; Nagasawa T; Ikeda U
    Cardiovasc Res; 2009 Jan; 81(1):169-77. PubMed ID: 18791205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
    Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
    Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein z exerts pro-angiogenic effects and upregulates CXCR4.
    Butschkau A; Wagner NM; Genz B; Vollmar B
    PLoS One; 2014; 9(12):e113554. PubMed ID: 25474349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival.
    Chatterjee M; Seizer P; Borst O; Schönberger T; Mack A; Geisler T; Langer HF; May AE; Vogel S; Lang F; Gawaz M
    FASEB J; 2014 Jul; 28(7):2864-78. PubMed ID: 24668750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model.
    Chua S; Sheu JJ; Chen YL; Chang LT; Sun CK; Leu S; Sung HC; Tsai TH; Chung SY; Yeh KH; Cho CL; Kao YH; Yip HK
    Cytotherapy; 2013 Sep; 15(9):1148-63. PubMed ID: 23849976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF-1α/CXCR4 pathway.
    Zhang MF; Wang JH; Sun S; Xu YT; Wan D; Feng S; Tian Z; Zhu HF
    Phytomedicine; 2024 Jun; 128():155362. PubMed ID: 38522312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.